For persons with drug-resistant focal onset seizures, a

Age

18 years - 99 years

Gender

All

participants needed

120

Location

Find a site

For persons with drug-resistant focal onset seizures, a type of Epilepsy, the study of of cvl-865 as adjunctive therapy.

Brief description of study

Trial of CVL-865 as Adjunctive Therapy in Adults With Drug-Resistant Focal Onset Seizures

Eligibility of study

You may be eligible for this study if you meet the following criteria:

Conditions: Epilepsy,focal onset seizures
Age: 18 years - 99 years
Gender: All

Male or Female, Age 18 or older focal onset seizures, a type of Epilepsy,

Updated on 04 Aug 2024. Study ID: 834546

Find a site

Your Information has been sent successfully.

We have submitted the contact information you provided to the research team at {{SITE_NAME}}. A copy of the message has been sent to your email for your records.

Would you like to be notified about other trials? Sign up for Patient Notification Services.

Send a message

Enter your contact details to connect with study team

View email

Phone

View phone

Primary Contact

First name*

Last name*

Email*

Phone number*

Preferred way of contact

Please provide your preferred way of contact

Other language

By Submitting your information, you agree that your details may be shared with the selected study site and handled in accordance with this Website's Privacy Policy (see link in footer). You may be contacted by email, text message, or phone regarding this study and other research opportunities that may be of interested to you. You can unsubscribe from these communications at any time. Message and data rates may apply.

Interested in the study

Select a study center that’s convenient for you, and get in touch with the study team.

Contact a study center

For persons with drug-resistant focal onset seizures, a type of Epilepsy, the study of of cvl-865 as adjunctive therapy.

Brief description of study

Eligibility of study

Find a site

Interested in the study